RV1729

Home
Ligands
RV1729

Ligand id: 10162

Name: RV1729

Structure and Physico-chemical Properties

2D Structure

Calculated Physico-chemical Properties
Hydrogen bond acceptors	9
Hydrogen bond donors	2
Rotatable bonds	15
Topological polar surface area	163.51
Molecular weight	734.27
XLogP	5.8
No. Lipinski's rules broken	2

Molecular properties generated using the CDK

Classification
Compound class	Synthetic organic

IUPAC Name
6-[2-[[4-amino-3-(3-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3-[(2-chlorophenyl)methyl]-4-oxoquinazolin-5-yl]-N,N-bis(2-methoxyethyl)hex-5-ynamide

IUPAC Name

6-[2-[[4-amino-3-(3-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3-[(2-chlorophenyl)methyl]-4-oxoquinazolin-5-yl]-N,N-bis(2-methoxyethyl)hex-5-ynamide

Synonyms
RV-1729

Synonyms

RV-1729

Comments
RV1729 is a clinical stage PI3Kγδ inhibitor that is being developed by Janssen Biotech subsidiary RespiVert (and licensed to Pulmatrix in 2017). The chemical structure is claimed in patent WO/2012/052753 [1-2].

Comments

RV1729 is a clinical stage PI3Kγδ inhibitor that is being developed by Janssen Biotech subsidiary RespiVert (and licensed to Pulmatrix in 2017). The chemical structure is claimed in patent WO/2012/052753 [1-2].

Database Links
BindingDB Ligand	200639
CAS Registry No.	1293915-42-0 (source: PubChem)
ChEMBL Ligand	CHEMBL3919512
GtoPdb PubChem SID	381118872
PubChem CID	52913198
Search Google for chemical match using the InChIKey	UBLOHCIYTDRGJH-UHFFFAOYSA-N
Search Google for chemicals with the same backbone	UBLOHCIYTDRGJH
Search UniChem for chemical match using the InChIKey	UBLOHCIYTDRGJH-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone	UBLOHCIYTDRGJH